Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron total assets
Total assets on the balance sheet at the end of each period.
Geron's total assets was $519.01M at Jun 30, 2026. For fiscal 2025 it was $570.54M, down 3.9% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is $593.78M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $570.54M | -3.9% |
| FY2024 | Dec 31, 2024 | $593.78M | +50.7% |
| FY2023 | Dec 31, 2023 | $394.08M | +106.8% |
| FY2022 | Dec 31, 2022 | $190.58M | -15.7% |
| FY2021 | Dec 31, 2021 | $226.03M | -16.5% |
| FY2020 | Dec 31, 2020 | $270.73M | +63.6% |
| FY2019 | Dec 31, 2019 | $165.52M | -10.7% |
| FY2018 | Dec 31, 2018 | $185.28M | +68.0% |
| FY2017 | Dec 31, 2017 | $110.31M | -15.3% |
| FY2016 | Dec 31, 2016 | $130.25M | -12.4% |
| FY2015 | Dec 31, 2015 | $148.76M | -13.8% |
| FY2014 | Dec 31, 2014 | $172.51M | +156.2% |
| FY2013 | Dec 31, 2013 | $67.34M | -32.5% |
| FY2012 | Dec 31, 2012 | $99.80M | -37.6% |
| FY2011 | Dec 31, 2011 | $160.05M | -31.5% |
| FY2010 | Dec 31, 2010 | $233.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $519.01M | -6.5% |
| Q1 FY2026 | Mar 31, 2026 | $534.12M | -5.0% |
| Q4 FY2025 | Dec 31, 2025 | $570.54M | -3.9% |
| Q3 FY2025 | Sep 30, 2025 | $567.38M | +27.5% |
| Q2 FY2025 | Jun 30, 2025 | $555.20M | +23.5% |
| Q1 FY2025 | Mar 31, 2025 | $562.45M | +16.7% |
| Q4 FY2024 | Dec 31, 2024 | $593.78M | +50.7% |
| Q3 FY2024 | Sep 30, 2024 | $444.95M | +7.7% |
| Q2 FY2024 | Jun 30, 2024 | $449.40M | +8.2% |
| Q1 FY2024 | Mar 31, 2024 | $482.07M | +13.5% |
| Q4 FY2023 | Dec 31, 2023 | $394.08M | +106.8% |
| Q3 FY2023 | Sep 30, 2023 | $413.02M | +77.6% |
| Q2 FY2023 | Jun 30, 2023 | $415.30M | +74.4% |
| Q1 FY2023 | Mar 31, 2023 | $424.88M | +114.1% |
| Q4 FY2022 | Dec 31, 2022 | $190.58M | -15.7% |
| Q3 FY2022 | Sep 30, 2022 | $232.61M | +1.5% |
| Q2 FY2022 | Jun 30, 2022 | $238.16M | -5.6% |
| Q1 FY2022 | Mar 31, 2022 | $198.42M | -23.3% |
| Q4 FY2021 | Dec 31, 2021 | $226.03M | -16.5% |
| Q3 FY2021 | Sep 30, 2021 | $229.10M | -19.8% |
| Q2 FY2021 | Jun 30, 2021 | $252.18M | -8.2% |
| Q1 FY2021 | Mar 31, 2021 | $258.61M | +81.0% |
| Q4 FY2020 | Dec 31, 2020 | $270.73M | +63.6% |
| Q3 FY2020 | Sep 30, 2020 | $285.79M | +74.0% |
| Q2 FY2020 | Jun 30, 2020 | $274.81M | +65.3% |
| Q1 FY2020 | Mar 31, 2020 | $142.89M | -18.7% |
| Q4 FY2019 | Dec 31, 2019 | $165.52M | -10.7% |
| Q3 FY2019 | Sep 30, 2019 | $164.25M | -12.6% |
| Q2 FY2019 | Jun 30, 2019 | $166.23M | -9.3% |
| Q1 FY2019 | Mar 31, 2019 | $175.67M | +66.5% |
| Q4 FY2018 | Dec 31, 2018 | $185.28M | +68.0% |
| Q3 FY2018 | Sep 30, 2018 | $187.93M | +64.5% |
| Q2 FY2018 | Jun 30, 2018 | $183.27M | +47.5% |
| Q1 FY2018 | Mar 31, 2018 | $105.51M | -18.1% |
| Q4 FY2017 | Dec 31, 2017 | $110.31M | -15.3% |
| Q3 FY2017 | Sep 30, 2017 | $114.24M | -16.1% |
| Q2 FY2017 | Jun 30, 2017 | $124.28M | – |
| Q1 FY2017 | Mar 31, 2017 | $128.85M | – |
| Q4 FY2016 | Dec 31, 2016 | $130.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $136.23M | – |
See a number that looks wrong?